review Open AccessTop 1% cited
Epidemiology of Renal Cell Carcinoma
European Urology · 2018 · Vol. 75(1) · pp. 74–84
Umberto Capitanio✉(Vita-Salute San Raffaele University)Karim Bensalah(Centre Hospitalier Universitaire de Rennes)Axel Bex(The Netherlands Cancer Institute)Stephen A. Boorjian(Mayo Clinic in Arizona)Freddie Bray(Centre international de recherche sur le cancer)Jonathan Coleman(Memorial Sloan Kettering Cancer Center)John L. Gore(Seattle Cancer Care Alliance)Maxine Sun(Brigham and Women's Hospital)Christopher G. Wood(The University of Texas MD Anderson Cancer Center)Paul Russo(Memorial Sloan Kettering Cancer Center)
Renal cell carcinoma treatmentMultiple and Secondary Primary CancersBladder and Urothelial Cancer TreatmentsMedicineRenal cell carcinomaIncidence (geometry)EpidemiologyContext (archaeology)Kidney diseaseObesityMortality rateDiseaseInternal medicine
MeSH terms
Carcinoma, Renal CellHumansKidney NeoplasmsRisk FactorsGlobal Health
Citations
1,613
FWCI
87.42
field-weighted impact
References
53
Percentile
100%
vs. same field & year
Citations per year
Cited by
Epidemiology of Renal Cell Carcinoma: 2022 Update
European Urology · 2022 · 700 citations
References
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
European Journal of Cancer · 2013 · 5,233 citations
Cancer statistics, 2018
CA A Cancer Journal for Clinicians · 2018 · 16,944 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.